{
  "id": "cluster_1_doc2",
  "content": "Policy update memo: Effective June 1, 2023, all neuromodulation devices require prior authorization with documented treatment failure of at least two anti-seizure medications. This change impacts 12% of active neurology patients in Region 4. Claims submitted without proper documentation will be denied.",
  "metadata": {
    "format": "policy_document"
  }
}